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Promoting remyelination is crucial for patients with demyelinating diseases including
multiple sclerosis. However, it is still a circuitous conundrum finding a practical
remyelinating therapy. Electroacupuncture (EA), originating from traditional Chinese
medicine (TCM), has been widely used to treat CNS diseases all over the world, but
the role of EA in demyelinating diseases is barely known. In this study, we examined
the remyelinating properties and mechanisms of EA in cuprizone-induced demyelinating
model, a CNS demyelinating murine model of multiple sclerosis. By feeding C57BL/6
mice with chow containing 0.2% cuprizone for 5 weeks, we successfully induce
demyelination as proved by weight change, beam test, pole test, histomorphology, and
Western Blot. EA treatment significantly improves the neurobehavioral performance at
week 7 (2 weeks after withdrawing cuprizone chow). RNA-seq and RT-PCR results
reveal up-regulated expression of myelin-related genes, and the expression of myelin
associated protein (MBP, CNPase, and O4) are also increased after EA treatment,
indicating therapeutic effect of EA on cuprizone model. It is widely acknowledged that
microglia exert phagocytic effect on degraded myelin debris and clear these detrimental
debris, which is a necessary process for subsequent remyelination. We found the
remyelinating effect of EA is associated with enhanced clearance of degraded myelin
debris as detected by dMBP staining and red oil O staining. Our further studies
suggest that more microglia assemble in demyelinating area (corpus callosum) during
the process of EA treatment, and cells inside corpus callosum are mostly in a plump,
ameboid, and phagocytic shape, quite different from the ramified cells outside corpus
callosum. RNA-seq result also unravels that most genes relating to positive regulation of
phagocytosis (GO:0050766) are up-regulated, indicating enhanced phagocytic process
after EA treatment. During the process of myelin debris clearance, microglia tend to
change their phenotype toward M2 phenotype. Thus, we also probed into the phenotype
of microglia in our study. Immuno-staining results show increased expression of CD206
and Arg1, and the ratio of CD206/CD16/32 are also higher in EA group. In conclusion,
these results demonstrate for the first time that EA enhances myelin debris removal from
activated microglia after demyelination, and promotes remyelination.
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INTRODUCTION
Multiple sclerosis (MS) is an autoimmune-mediated
demyelinating disease of central nervous system (CNS),
with a hallmark of extensive demyelination in the CNS. Though
clinically, there is no ideal treatment for MS hitherto, disease
modifying therapies (DMTs) are the mainstream for MS
treatment (Oh and O’Connor, 2015). Currently approved DMTs
are immunosuppressive and immunomodulatory agents. These
agents help prevent disease relapse and reduce the severity of
relapse to some extent (Cross and Naismith, 2014; Wingerchuk
and Carter, 2014). However, DMTs can only partially postpone
the relapse of MS and slightly reduce the accumulation of
physical disabilities. Besides, high cost and side effect of DMT
is also unfavorable for MS patients (Adelman et al., 2013;
Carrithers, 2014; Winkelmann et al., 2015). The process of
remyelination is directly and closely related to the restoration
of neuronal function and the amelioration of clinical disabilities
(Nave, 2010; Harlow et al., 2015; Olsen and Akirav, 2015).
However, DMTs have limited impact on remyelination. So far,
no practical remyelinating therapy has been applied clinically
and nearly all potential remyelinating methods are still under
development (Hartley et al., 2014).
Acupuncture as well as electroacupuncture (EA), a therapeutic
intervention originating from traditional Chinese medicine
(TCM), has long been used to treat various disorders (Wootton,
1997). Compelling evidence demonstrates that acupuncture is
beneficial in preventing neuronal injury in various pathological
conditions, such as stroke, cerebral palsy, depression, etc
(Han and Ho, 2011; Kwon et al., 2012; Xu et al., 2013;
Bai et al., 2014; MacPherson et al., 2014; Yang et al.,
2014). Clinical reports have yielded promising evidence of
acupuncture ameliorating symptoms of MS patients, such as
fatigue, bladder dysfunction, spasticity, and eventually improving
quality of life (Tjon et al., 2009; Kopsky and Hesselink,
2012; Quispe-Cabanillas et al., 2012; Foroughipour et al.,
2013). In addition, Laboratory studies based on experimental
autoimmune encephalomyelitis (EAE) model, a classic animal
modelmainlymimicking the immunopathology ofMS, also show
that EA treatment inhibit the proliferation of encephalitogenic
T cells, increase the secretion of ACTH and β-endorphin,
and eventually ameliorate EAE (Park et al., 2004; Liu et al.,
2013). A recent study indicates that EA promotes remyelination
in compressed spinal cord injury (SCI) model by enhancing
the proliferation of oligodendrocyte precursor cells (Huang
et al., 2015). Additionally, EA promotes the differentiation of
the transplanted bone marrow mesenchymal stem cells into
oligodendrocyte-like cells in SCI model (Ding et al., 2013; Liu
et al., 2015).
SCI model is a traumatic local demyelinating model
rather than a systematic demyelinating model (Ransohoff,
2012; Procaccini et al., 2015). Hence, we introduce cuprizone
(CPZ)-induced demyelinating model in our study. CPZ-
induced demyelinating model is a classic rodent model
allowing the investigation specifically in CNS demyelination and
remyelination (Kipp et al., 2009; Zendedel et al., 2013; Praet
et al., 2014). By feeding mice with chow containing 0.2% CPZ
for 5 weeks, significant CNS demyelination can be induced,
with corpus callosum (CC) being the most vulnerable region
(Steelman et al., 2012; Praet et al., 2014). After removal of
CPZ from diet, spontaneous remyelination occurs over time.
Therefore, CPZ model is a systematic model for the study of
demyelination and remyelination of MS. It is unclear whether EA
is effective in CPZ model and the underlying mechanisms of EA
in promoting remyelination remain unraveled.
Previous studies have confirmed that CPZ-induced
demyelination is accompanied with extensive accumulation
of degraded myelin debris and activation of glial cells, chiefly
CNS microglia and astrocytes (Praet et al., 2014). Microglia is
verified to play an important role in the process of remyelination
(Voss et al., 2012; Miron et al., 2013; Doring et al., 2015; Lampron
et al., 2015). Accumulating evidence suggests that microglia is
associated with the clearance and phagocytosis of degraded and
collapsed myelin debris, existence of which is detrimental to
OPC proliferation and remyelination (Kotter et al., 2005, 2006;
Ruckh et al., 2012; Kocur et al., 2015). Studies also found that
microglia, especially M2 phenotype, are positively related to
the recruitment of OPCs and their differentiation into mature
oligodendrocytes, as well as myelin formation (Miron et al.,
2013; Wang et al., 2015; Marteyn et al., 2016). Although EA
shows a therapeutic effect on various neurodegenerative diseases
achieved by its ability to alleviate existing neuroinflammation
and glial dysfunction, it is unclear whether EA could modulate
microglia function during the process of demyelination and
remyelination.
The current studies were performed to understand the
therapeutic effect and potential mechanisms of EA in CPZ-
induced demyelinating model. We assessed the neurobehaviors
in CPZ fed and EA treated mice and the expression of myelin
associatedmarkers, and probed into themechanisms by assessing
the production of degraded myelin debris and the recruitment of
microglia into CC as well as the phenotype of microglia in CC. To
our knowledge, this is the first study ever focusing on the function
of EA in CPZ-induced demyelinating model and the regulatory
effect of EA on microglia in demyelinating diseases.
MATERIALS AND METHODS
Animals and CPZ Feeding Scheme
Male C57BL/6 mice aged between 5 and 6 weeks, acquired
from the Experimental Animal Center, Chinese Academy of
Sciences (Shanghai, China), were used in the present study.
To induce demyelination, mice were fed with standard rodent
chow containing 0.2% CPZ powder (Sigma-Aldrich, St. Louis,
MO, USA) for 5 weeks. After 5 weeks’ induction, CPZ was
removed and replaced with standard diet for 2 weeks allowing for
spontaneous remyelination. All protocols were performed and
approved in accordance with the National Institutes of Health
Guide for the Care and the Animal Research Welfare Council of
School of Basic Medical Science of Fudan University (20140266-
086). All endeavors were made as far as possible to reduce
the sacrifice of animals and relieve their sufferings during the
experiments.
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Electroacupuncture (EA) Treatment
EA treatment started from the first day of week 5 and lasted for 3
weeks. Mice received 30 min EA treatment once every other day.
Two acupoints in the governor vessel (GV) were adopted, which
is Baihui (GV20) and Zhiyang (GV9). A pair of stainless needles
with diameters of 0.3 mm (Suzhou Medical Supplies, Suzhou,
P.R. of China) were obliquely and subcutaneously inserted into
GV9 and GV20 to a depth of 5 mm or so but exterior to the
harnpan and vertebral canal. The pair of needles were then
connected with an output terminal of an EA apparatus (HANS
Acupoint Nerve Stimulator, LH202H, Beijing, P.R. of China),
with alternating strains of dense-sparse frequencies of 2/15 Hz
and stimulating current of 3–4 mA. Mice were restrained by an
apparatus made by our lab specially for the EA treatment. All
other mice groups have been restrained the same way. In our
preliminary study, we have set up a group of sham-EA. Mice
in sham-EA group received the same acupuncture treatment
without electric stimulation.
Beam Walking Test
The assessment of mice locomotor coordination was performed
by beam walking test (Skripuletz et al., 2010). In brief, mice were
trained to traverse a 1.5 cm narrow wood beam to reach a so-
called safety box with paddings inside, which created a relatively
safe environment encouraging mice to traverse the beam. Mice
were placed on one end of the 100 cm long beam (horizontally 60
cm above the platform), and the traversing times were recorded.
To reduce errors, the time mice spent on both ends (10 cm of
each end) were neglected, only the time spent in themiddle 80 cm
of the beam were recorded. As displayed in Video 1, we started
recording at the moment hind limbs of mice passing the START
line on the beam, and end recording at the moment fore limbs
of mice touching the END line on the beam. Mice received two
consecutive trials in each test and the mean time of two trials
was used for statistical analysis (cut-off time 60 s). Thick cotton
cushions were placed under the beam in case mice slip down.
Pole Test
Pole test was performed according to previous reports withminor
adjustments (Lin et al., 2013). In brief, mice were placed tenderly
head-up facing the apex of a vertical round wood pole (diameter:
1 cm; height: 50 cm) with gauze-wrapped rough surface enabling
mice to grab. The time mice climbing over the apex of pole
with head facing down and body in a vertical position (turn-
back time), and the time mice descending to the bottom of the
pole after climbing over (touch-down time) were recorded for
analysis (Video 3). The cut-off time was 30 and 60 s for turn-back
time and touch-down time, respectively. In each test, each mouse
conducted two consecutive trials and the average time of two
trials was recorded for statistical analysis. Thick cotton cushions
were placed under the pole in case mice fall off.
Histological Analysis
Mice were gently anesthetized with saline solution of
pentobarbital sodium (70 mg/kg, i.p.) and perfused with
4% paraformaldehyde. The cerebra were resected and serial 4
µm paraffin sections were stained with hematoxylin and eosins
(HE) or luxol fast blue (LFB) to assess demyelination within the
area of CC. For HE staining, the process was conducted following
our previous protocol (Wang et al., 2012). For LFB staining,
paraffin tissues were stained in LFB/cresyl violet overnight at
55◦C, followed by washing in 95% ethanol and double-distilled
water to remove redundant dye. Then, the white matter of the
sections was distinguished from the gray matter in a lithium
carbonate solution for about 15 s (until easily distinguishable).
Later on, the sections were washed by double-distilled water and
75% ethanol.
Red Oil O Staining
After drying in 100% propylene glycol, brain tissues were stained
with 0.5% Red Oil O solution (Sigma, USA) at a temperature of
60◦C for 6 min. After that the brain slices were incubated with
85% propylene glycol for 2 min following by rinsing. Nuclei were
stained with haema-toxylin (Sigma, USA).
Immunofluorescence
Paraffin sections (4 µm) were used for MBP (1:200, Millipore,
AB980) and dMBP (1:2000, Millipore, AB5864) staining to
determine the degree of myelination and the production of
degraded myelin debris respectively. Frozen sections (25 µm)
were prepared for staining with Iba1 (1:400, Wako, Japan), Arg1
(1:200, Santa Cruz, USA), iNOS (1:200, Santa Cruz, USA), CD206
(1:100, R&D, USA), CD16/32 (1:500, BD, USA), and O4 (1:50,
Millipore, USA) to determine the recruitment of microglia into
the area of CC and the phenotype of the recruited microglia.
The sections were first washed three times and blocked with 4%
goat serum in 0.3% Triton X-100 for 3 h at room temperature
followed by incubation with antibodies described above at 4◦C
for 12 h followed by Alexa Fluor 488 or 555 goat anti-rabbit
secondary antibodies (1:1000, Invitrogen, USA) at 37◦C. All
sections were treated with Fluorescence Decay Resistant Medium
with DAPI before being covered with coverslip. The images were
captured by a multiphoton laser scanning confocal microscopy
system (Olympus Fluoview FV1000) or common fluorescence
microscope (Leica DMI6000).
Western Blot Analysis
Western blot was performed to quantify the expression of
MBP. The brain was removed and CC tissue was quickly
resected on ice. The CC was ultrasonically homogenized
in radioimmunoprecipitation assay lysis buffer (RIPA
buffer, Beyotime, Shanghai, China) followed by 12,000 rpm
centrifugation for 10 min and the supernatant was collected
for western blot analysis. Equal amounts of protein samples
(20 µg of total protein) were analyzed by SDS-PAGE with
primary antibodies being either rabbit anti-MBP (1:500,
Millipore, AB980) or anti-GAPDH (1:10000, Proteintech, HRP-
60004). Proteins were detected via incubation with horseradish
peroxidase-conjugated secondary antibodies and an ECL
chemiluminescence detection system (Tanon, Shanghai, China).
The images were obtained using an ImageQuant LAS4000 mini
image analyzer (GE Healthcare, Buckinghamshire, UK).
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RNA Sequencing (RNA-seq) Analysis
Total RNA was prepared using the Qiagen RNeasy kit. Libraries
were prepared using the NEBNext Library Prep Kit (New
England Biolabs) according to the manufacturer’s instructions.
Library quality was assessed using a Bioanalyzer (Agilent) and
then the samples were sequenced on the Illumina Hiseq 2000
with a goal of 30 million reads per sample. Raw FASTQ files
were aligned using PRADA and FPKM values obtained using
Cuﬄlinks for gene expression analysis.
Quantitative RT-PCT (qRT-PCR) Analysis
To evaluate the mRNA expression of genes related to
oligodendrocyte lineage and myelination, the corpus callosum
were dissected 7 weeks after the first day of cuprizone feeding;
total RNA were isolated using Trizol reagent (Invitrogen,
USA). The relative abundance of target mRNAs were then
quantified using SYBR Green qRT-PCR detection (Light Cycler
96 real-time PCR detection system, Roche, Switzerland). The
primer sequences of target mRNA are listed in Table 1. The
housekeeping gene, HPRT, was used as an internal reference
for standardization of the analysis. Relative quantification was
performed by determination of the n-fold differential expression
with the 2−11Ct method and is expressed as relative fold change
compared to HPRT. Melting curves were used to establish the
purity of the amplified band. The PCR products were sequenced
to confirm identity.
Image Analysis
Western blot bands and immunofluorescence staining
(integrated optical density, IOD) were analyzed using ImageJ
software. The quantitative statistical graphs were created based
on the relative fold change.
Statistical Analysis
All quantitative data were presented as mean± standard error of
the mean (S.E.M.). Statistical analysis and graphs were obtained
using Graphpad 5.0 software. Differences between groups were
analyzed with Student’s t-test and one-way analysis of variance
(ANOVA) followed by LSD post-test or Bonferroni post-test.
Values of P < 0.05 were regarded as the criteria of significance.
TABLE 1 | Primers used for RT-PCR analysis.
Genes Species Primers (5′–3′)
MBP Mouse FW:AAGTACCTGGCCACAGCAAG
RE:AGCTTCTCTACGGCTCGGA
MAG Mouse FW:TCTCTACCCGGGATTGTCACT
RE:CGGATTTCTGCATACTCAGCCA
CNP Mouse FW:AGAGTGATCCTTGGAGCCAGA
RE:CGGAGGGGAATGGTGGATTT
PLP1 Mouse FW:CTGAGCGCAACGTTTGTGG
RE:TACATTCTGGCATCAGCGCA
RESULTS
CPZ Administration Induces
Neurobehavioral Defects and Severe
Demyelination
During the first 10 days after CPZ administration, we observed
obvious weight loss of CPZ fed mice compared to mice with
normal diet (Figure 1A). Two weeks later, CPZ fed mice
gradually regained weight, but still did not weigh as much as the
normal group. CPZ feeding can lead to extensive demyelination
in many regions of brain including hippocampus, cerebellum,
cortex, and with corpus callosum (CC) the most vulnerable one,
which results in motor coordination impairment. To evaluate
the motor coordinative function, beam walking test and pole
test were performed. Mice exposed to CPZ exhibited severe
coordinative locomotor dysfunction with the peak at and around
week 4 (Figures 1B–D; Videos 1–4). As shown in the videos, in
beam test CPZ fed mice tended to be more hesitant traversing
the beam with more fumbles and pauses; in pole test, CPZ
fed mice had more difficulty in climbing over the apex of
the pole. However, the touch-down time in pole test was not
affected by CPZ (Data sheet 1, Figure S1). No mice fell off
or slipped over from the beam or pole during our behavioral
tests. CC is previously reported as the most vulnerable region
during CPZ treatment (Steelman et al., 2012). Thus, we evaluated
the histomorphological change of CC region by HE and LFB
staining and observed conspicuous demyelination in CC after
CPZ treatment for 5 weeks (Figures 1E,G). Myelin basic protein
(MBP) is the main component of oligodendrocyte as well as
myelin within CC. Therefore, we further detected the amount
of MBP in CC by western blot and verified obvious decrease of
MBP in CPZ fed mice (Figure 1F). Those results clearly indicate
a successful establishment of CPZ induced demyelinating model.
EA Modulates Neurobehavioral
Dysfunction of Demyelinating Mice
To examine the effect of EA on the neurological behaviors of
mice with demyelination, we performed beam walking test and
pole test, which aim to examine motor coordinative function
in association with ataxia, which is one of the main clinical
features of MS patients. Previously, we compared the effect of
EA treatment and sham-EA treatment (described in Section
Materials and Methods), and our preliminary results indicate
that sham-EA treatment exert little effect on remyelination
(Data sheet 1, Figure S2). Thus, to reduce unnecessary sacrifice
of mice under the consideration of animal welfare, we excluded
sham-EA group for the following experiments. EA treatment
started at the beginning of week 5 and lasted for 3 weeks
until mice were sacrificed at the end of week 7 (Figure 2A).
Baihui (GV20) and Zhiyang (GV9) acupoints were used for EA
treatment (Figure 2B). Mice receiving EA treatment exhibited a
better performance in beam walking test (Figure 2C) and turn-
back time in pole test (Figure 2D). Two weeks EA administration
already effectively decreased the traverse time in beam walking
test (Figure 2C); and the traverse time in beam test and turn-
back time in pole test completely reverted back to normal by the
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FIGURE 1 | CPZ administration induces severe demyelinating related changes. Mice were fed with chow containing 0.2% CPZ powder for 5 weeks. (A)
Consecutive body weight change during 5 weeks (n = 10 for both group). (B) Reverse time of beam walking test and (C) turn-back time of pole test in CPZ fed mice
(n = 10 for both groups). (D) CPZ fed mice exhibited the most detectable defects in neurobehaviors at week 4. Pathological changes of demyelination were assessed
by (E) HE staining and (G) LFB staining after 5 weeks of CPZ administration (scale bar = 50 µm). (F) The expression of MBP were detected by Western Blot (left), and
the quantitative data of MBP expression were displayed as relative fold change compared to normal group (right, n = 4/group). All data represents the means ±
S.E.M. (*p < 0.05, **p < 0.01, ***p < 0.001 compared to normal group).
end of the treatment. However, the touch-down time in pole test,
which mainly indicating the muscular strength of forelimbs, was
not affected either by CPZ (Figure S1) or EA treatment (data not
shown). These results prompt us to conclude that EA modulates
neurobehavioral dysfunction associated with demyelination, and
that muscle strength of forelimbs was not affected either by CPZ
or EA treatment.
EA Promotes Remyelination in Corpus
Callosum
CC is the most evident and notable region of demyelination in
CPZ model. Thus, to evaluate the effect of EA on remyelination,
we applied RNA-seq to the transcriptome of CC tissue from
normal mice, CPZ fed mice and CPZ + EA treated mice at the
end of week 7. We focused on the expression profiles of genes
relating to myelin components, nodal/paranodal proteins, and
some transcription factors that play a role in oligodendrocyte
development. The RNA-seq results (Data sheet 2) revealed
remarkably reduced expression of most genes in CPZ group,
while EA treatment reversed the reduction and stimulated
the expression of most of those myelin-related genes, notably
CNP, PLP1/2, CLDN11, and CNTNAP3 (Figure 3A). To further
confirm the results, we applied RT-PCR experiments to detect
the mRNA expression of genes encoding proteins of myelin
components and the results were basically in accordance with
RNA-seq results (Figures 3B–E). Myelin basic protein (MBP)
is the main component of myelin sheath, and the anti-MBP
antibody is one of the most commonly used markers to examine
the amount of myelin and the integrity of an intact myelin
structure; CNPase is also a myelin protein which is exclusively
expressed by lineage of oligodendrocytes in the CNS. To further
verify the efficacy of EA in remyelination, we examined the
expression of MBP and CNPase in CC by using western blot. At
week 5, we did not observe obvious difference in the expression
of MBP or CNPase between CPZ group and EA group; however,
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FIGURE 2 | Amelioration of neurological behaviors after 3 weeks of EA treatment. (A) The scheme of experiment: CPZ administration was withdrawn after 5
weeks, followed by 2 weeks of remyelination until mice were sacrificed. Mice received 3 weeks of EA treatment since the 1st day at week 5, when they started
exhibiting severe defects in neurological behaviors. (B) The location of Baihui (GV20) and Zhiyang (GV9) acupoints; EA treatment significantly reduced the time spent in
(C) beam walking test and (D) turn-back time in pole test at week 7. Data represents the means ± S.E.M. (n = 10–11/group, *p < 0.05, **p < 0.01).
EA treatment for 3 weeks caused significantly increased protein
expression of MBP and CNPase in CC region compared to
CPZ group (Figures 3F–H). Similar results were also obtained
from immunofluorescence experiments. Since demyelination in
corpus callosum is uneven (more severe in caudal part), we
detected demyelination in both caudal and rostral part of corpus
callosum (Figure 3I) with MBP and O4. At week 7, CPZ fed mice
showed decreased myelin integrity compared to normal mice as
detected by MBP and O4 staining, whereas EA can significantly
enhance the expression of MBP and O4 and rebuild dense myelin
sheaths (Figures 3J,K). Taken together, these results confirm the
efficacy of EA on remyelination.
EA Promotes the Clearance of Degraded
Myelin Debris
In CPZ demyelinating model, demyelination is followed by
accumulation of degraded myelin debris and activation of glial
cells (Praet et al., 2014). It is reported that the accumulation
of myelin debris is detrimental to CNS axonal remyelination
by inhibiting the differentiation of OPC (Kotter et al., 2006).
Thus, the removal and clearance of degraded myelin debris,
generated during the process of demyelination, is a critical step
for remyelination process (Lampron et al., 2015). To test whether
the effect of EA on remyelination is related to the clearance of
myelin debris, an antibody which specifically binds degraded
myelin basic protein (dMBP) was used. This dMBP antibody is
an important tool to study myelin debris, which has previously
been reported to bond a certain MBP epitope that is only
accessible in areas of myelin degeneration (Matsuo et al., 1997).
Consistent with previous study (Cantoni et al., 2015), we were
still able to find a certain amounts of degraded myelin debris
in CC compared to normal mice at week 7, when 2 weeks
after CPZ has already been withdrawn. However, 3 weeks of EA
treatment significantly reduced the existence of myelin debris
(Figures 4A,B). To further confirm this result, we performed red
oil O staining to detect the presence of lipid-rich myelin debris.
Degraded myelin debris tend to display dark-red deposits and
clumps in red oil O staining (Weinger et al., 2011). We found
that EA treatment for 3 weeks also reduced dark-red clumps as
compared to CPZ group at week 7 (Figure 4C). Thus, we confirm
that EA treatment promotes clearance of degraded myelin debris,
which is beneficial for subsequent axonal remyelination.
More Phagocyte-Like Microglial Cells
Assemble into CC During EA Treatment
Compelling evidence suggests that microglia, especially M2-
polarized cells, confer neuroprotection in MS through enhancing
clearance and phagocytosis of degraded myelin debris, as well
as recruiting OPCs to promote remyelination (Jurevics et al.,
2002; Mikita et al., 2011; Vaknin et al., 2011; Olah et al.,
2012). In this regard, we reasoned that the decrease of degraded
myelin debris and the promotion of remyelination resulting
from EA treatment could be related to the regulatory effect
of EA on microglia. To prove this hypothesis, microglia in
areas of CC were assessed by staining Iba1. The CPZ model
is a demyelinating model of non-autoimmune character with
intact brain-blood barrier hardly ever allowing large amount
of peripheral monocytes/macrophages to infiltrate the CNS
(McMahon et al., 2002; Remington et al., 2007). Additionally,
previous studies rarely distinguished brain-resident microglia
from macrophages of peripheral origin, with the two cell types
being phenotypically nearly the same. For this reason, in this
study we refer to microglia/macrophages as microglia.
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FIGURE 3 | EA promotes remyelination in corpus callosum. (A) Heatmap shows RNA-Seq results of gene expression in corpus callosum at week 7. (B–E) mRNA
level of genes of oligodendrocyte lineage (MBP, CNP, PLP1, MAG) in each group at week 7 (n = 4 for each group). (F) The protein expression of MBP and CNPase in
each group at week 5 and week 7. (G,H) Bar graph shows the quantification of MBP and CNPase expression in (F) (n = 4 for each group). (I) The area of interest
within the corpus callosum (yellow frame). The brain altas of mice is a pubic data from Harvard University (http://www.hms.harvard.edu/research/brain/atlas.html). The
upper section (Label 305 of the atlas) is for MBP staining, and the lower section is for O4 staining. (J,K) Immunostaining of MBP and O4 showing the structure of
myelin sheath (n = 4 for each group; scale bar = 50 µm). All data represents the means ± S.E.M. (*p < 0.05, **p < 0.01, ***p < 0.001 compared to normal group).
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FIGURE 4 | EA treatment enhances the clearance of degraded myelin debris. (A) The immunofluorescence staining of degenerated myelin debris was
detected using dMBP antibody (red) using a confocal microscope (scale bar = 50 µm). (B) Bar graph shows the semi-quantification of integrated optical density (IOD)
for dMBP expression. (C) Red oil O staining showing lipid-associated deposit of degraded myelin debris. Data represents the means ± S.E.M. (n = 3–4/group, *p <
0.05 compared to normal and EA group).
At week 7, when EA treatment was in its 3rd week, more
microglia assembled into CC in EA group than CPZ group
(Figures 5A,B). Notably, we found the morphology of microglia
assembled into CC of EA group was quite different from that
of CPZ group as well as the microglia outside the CC in EA
group (Figures 5A,C,D). Microglia in CPZ group and in areas
outside the CC of EA group were mostly ramifiedmicroglial cells,
while microglia assembled into CC of EA group looked more
like phagocytic microglia for these cells generally displaying an
ameboid, plump shape, indicating an active phagocytic process
taking place in CC after EA treatment, which supposedly is
the cause for enhanced clearance of myelin debris. To further
prove it, we checked the gene expression relating to phagocytosis
according to the gene annotation of Postitive Regulation
of Phagocytosis (GO: 0050766) from AmiGo2 (http://amigo.
geneontology.org/amigo/term/GO:0050766). A large number of
phagocytosis-related genes were up-regulated after EA treatment
(Figure 5E). Taken together, these results prove that EA facilitates
microglia assembling into corpus callosum exerting phagocytic
function.
EA Facilitates the Change of Assembled
Microglia toward M2 Phenotype
It has been reported that microglia tend to change their
phenotype toward M2 phenotype during the process of
myelin debris clearance, and microglia with M2 property exert
protective effect in demyelination (Kotter et al., 2006; Neumann
et al., 2008; Skripuletz et al., 2013). Therefore, we conducted
immunofluorescence staining to detect expression of markers
of M2 and M1 phenotype on microglia in CC. The expression
of CD16/32 and iNOS (M1 markers) were elevated in both
CPZ group and EA group due to exposure to cuprizone, but
there is no difference of their expression between CPZ and EA
group (Figures 6B,C,E). On the contrary, we found significantly
elevated expression of CD206 and Arg1 (M2 markers) after EA
treatment compared to CPZ group (Figures 6B,D,E). Since we
observed elevated expression of Iba1 in corpus callosum at week
7 (Figures 5A,B), the increasd expression of M2 markers could
also result from the increased number of microglia assembling in
CC. So we then compared the CD206/CD16/32 ratio in different
groups and we found a higher CD206/CD16/32 ratio after EA
treatment. These results indicate that more microglia in corpus
callosum change their phenotype to M2 phenotype after EA
treatment (Figure 6F).
DISCUSSION
The goal of the current study was to determine the efficacy
of electroacupuncture on remyelination and to explore the
underlying mechanisms. In the present study, we demonstrated
the following: (1) EA promotes remyelination in CPZ-induced
demyelinating model and ameliorates the subdued motor
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FIGURE 5 | More microglial cells displaying ameboid and phagocytic shape assemble into corpus callosum during EA treatment. (A)Microglia assembing
into corpus callosum at week 7 was detected by Iba1 (green); nuclei was labeled by Dapi (blue). (B) Bar graph shows the semi-quantification of IOD of Iba1 positive
cells inside the area of corpus callosum (Data represents the means ± S.E.M.; n = 3/group, *p < 0.05 compared to cuprizone group). (C,D) Higher magnification of
indicated microglia in (A): (C) representative microglia outside the corpus callosum with ramified shape displaying more branches; (D) representative microglia
displaying ameboid and phagocytic shape inside the area of corpus callosum after EA treatment (E) A heatmap shows the gene expression of phagocytosis-related
genes (according to the gene annotation of “positive regulation of phagocytosis” from AmiGo2; GO: 0050766). Bar = 50 µm for (A); Bar = 20 µm for (C,D).
coordination impairments resulting from extensive CNS
demyelination; (2) EA significantly eliminates the accumulated
degraded myelin debris in CC; (3) the clearance and removal of
degraded myelin debris caused by EA is associated with more
microglia assembling into the area of CC; (4) microglial cells in
CC are mostly ameboid-shaped phagocytic cells with relatively
higher M2 property during EA treatment. These results not only
prove the efficacy of EA on remyelination, but also elucidate a
possible mechanism through which EA regulates the polarization
and function of microglia to enhance the clearance of myelin
debris.
Seeking feasible methods toward MS treatment is still
a long-cherished wish for neurological physicians and
neuroscientists globally. Despite much attention having
been drawn to immunotherapies in the past, promoting
remyelination in MS patients seems more and more crucial
because immunomodulatory therapies mainly play a part in
reducing immune activity and blocking the infiltration of
peripheral immune cells into CNS, but little is done to enhance
the process of remyelination (Hartley et al., 2014; Olsen and
Akirav, 2015). However, since demyelination is the most critical
pathological change of MS patients, which may directly influence
the locomotor functions and quality of life, remyelination
in lesion areas is indispensable for MS patients. Studies in
experimental model of MS have elucidated that preservation of
myelin sheath as well as enhancement of axonal remyelination
can improve neuronal function and halt the progression of
disability (Chari and Blakemore, 2002; Nave, 2010).
The slow progress in finding a practical cure for MS has
prompted us to expand our horizon and excavate potential
treatment from traditional medicine. Acupuncture is an ancient
treating method originating from TCM and is still being widely
used worldwide to treat CNS diseases (Zhao, 2008). Although
MS is currently not on the list of diseases recommended for
acupuncture treatment as assessed by National Institute of
Health and World Health Organization, it is still accepted as
a complementary therapy with certain curative effect. However,
the role of EA in MS and its experimental models remains to be
elucidated. Here in our study, we selected two acupoints, Baihui
(GV20) and Zhiyang (GV9), to implement EA treatment. The
reason why we chose the two acupoints are chiefly as follows:
1. Baihui (GV20) and Zhiyang (GV9) belong to the Governing
Vessel (Du meridian), which regulate brain activities and mental
disorders according to TCM (Sun et al., 2015; Wu et al., 2015);
2. Anatomically, the connection between this two acupoints
runs through cervical cord and brain, covering the demyelinated
lesion areas of CPZ fed mice.
The CPZ model we established in our lab exhibited analogous
characteristics as previously reported models, which included
obvious weight loss during the first 2 weeks, poor performance in
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FIGURE 6 | EA induces higher CD206/CD16/32 ratio in assembled microglia. (A) Immunofluorescence staining of CD206 (red), Iba1 (green), and Dapi (blue).
(B) Immunofluorescence staining of CD16/32 (red), Iba1 (green), and Dapi (blue). (C,D) Immunofluorescence staining of iNOS (green), Arg1 (red), and Dapi (blue). (E)
Statistical graph showing relative IOD expression of CD206, Arg1, CD16/32, and iNOS in different groups. (F) Statistical graph showing relative CD206/CD16/32 ratio
in different groups. Bar = 50 µm; data represents the means ± S.E.M. (n = 4/group, *p < 0.05 compared to cuprizone group).
beamwalking test, and severe demyelination after 5 weeks of CPZ
treatment (Skripuletz et al., 2010; Praet et al., 2014). To better test
the neurological behaviors, pole test was innovatively introduced
to CPZ model and we found that mice with demyelination
exhibited defects in turn-back performance, but not in touch-
down (descending) performance. It is possible that the behavior
of turning in pole test is a coordinative and collaborative motion
with the help of hind limbs while the behavior of descending
is mainly a motion that requires muscle strength of fore limbs.
From our observation, CPZ mice did not exhibit obvious defects
in muscle strength compared to the case of EAE mice (Wang
et al., 2012), and other studies also reported only mild paralysis
mainly in the hind limbs of CPZ treated mice rather than fore
limbs (Franco-Pons et al., 2007). Our results in pole test further
confirmed this and provided new information on the behavior of
CPZ mice.
Mice fed with CPZ showed a peak of sickness at and
around week 4, so we treated them from this time point to
the day they were sacrificed. We found that successive EA
treatments gradually improved the neurological behaviors and
promoted recovery of model mice. Nevertheless, we observed
some inevitable fluctuations in the results of behavioral tests
even in normal mice during the whole scheme of 7 weeks,
because there were too many factors that could affect behavioral
results, such as individual differences, weight change due to
feeding, stressors, learning abilities, etc (Bogdanova et al.,
2013). So we further examined the effects of EA by molecular
biological techniques and immuno-techniques. The results we
obtained indicate that EA treatment enhances the expression of
myelin-related components, which further support the results we
obtained from behavioral tests. Together with previous research
(Ding et al., 2013; Huang et al., 2015; Liu et al., 2015), we are
inclined to conclude that EA is an effective healing method to
facilitate remyelination in diseases with demyelination. However,
we found a disparity in our RT-PCT results: the mRNA
expression of MBP (also PLP1) at week 7 is not down-regulated
whereas the expression of MBP detected by Western Blot
and immuno-staining is reduced. Since cuprizone model is a
chronic demyelinating model with spontaneous remyelination,
we speculate that the mRNA expression of MBP/PLP1 might
revert to normal level at week 7. However, the existence of
myelin debris may postone the process of post-transcriptional
processing and post-transcriptional translation of protein, and
consequently result in delayed protein synthesis of MBP/PLP1.
Due to technical difficulties, we did not perform electron
microscopy to observe, ultrastructurally, the effect of EA on
remyelination, but this will be addressed in our ongoing studies.
Myelin debris is a pathological substance accumulated during
CPZ treatment and the process of demyelination in MS patients.
Previous studies have demonstrated that the existence of
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degraded myelin debris is harmful to remyelination and that the
speed of CNS remyelination is strongly correlated with the rate
of the phagocytosis and clearance of myelin debris (Kotter et al.,
2006; Lampron et al., 2015). The emergence of antibodies which
can detect degenerated myelin debris (dMBP) is a milestone in
the study of demyelinating diseases (Matsuo et al., 1997, 1998).
By using antibodies binding degraded myelin debris, we are now
able to detect degraded myelin debris and understand the role of
myelin debris in demyelinating diseases (Ye et al., 2007; Williams
et al., 2014). Though the role of microglia in MS as well as its
animal models is an object of dispute, accumulating evidence
suggests that microglia play a crucial role in the removal and
clearance of degraded myelin debris in CNS (Kotter et al., 2006;
Neumann et al., 2008; Rawji and Yong, 2013; Skripuletz et al.,
2013). Loss-of-function studies have proved that dysfunction
of microglia in demyelinating models will slower the rate of
clearance of myelin debris and postpone remyelination process
(Kotter et al., 2005; Weinger et al., 2011; Cantoni et al., 2015;
Kawabori et al., 2015; Lampron et al., 2015). However, it is
still not fully understood, whether higher amount of microglia
is beneficial to remyelination. Our results seem to provide
the first proof for remyelinating effect of larger population of
microglia. Using dMBP antibody, we tentatively made an attempt
to detect myelin debris after EA treatment, and much to our
surprise, EA exhibited unexpected ability to remove myelin
debris. Furthermore, we identified that the myelin clearing effect
of EA was mediated by elevated microglia assembling into corpus
callosum. RNA-seq result shows that most of the genes relating to
positive regulation of phagocytosis are up-regulated during EA
treatment. It is worth mentioning that all the Fc receptors in this
gene annotation are up-regulated after EA treatment. It’s well-
known that Fc receptors confer protective function in immune
system since they are actively involved in a wide variety of
process, mainly phagocytosis. Notably, Fc-gamma receptors are
also expressed on cells of oligodendrocyte lineage, and they are
reported to control the differentiation cascade of oligodendrocyte
that subsequently form myelin sheath, indicating a possible role
of Fc receptors in remyelination (Nakahara et al., 2003; Nakahara
and Aiso, 2006). In addition to this, it is intriguing that we
also found elevated expression of genes of complement system
(notably C3, C4). The complement components are highly
involved in the process of phagocytosis (Tyler and Boulanger,
2012) and C3/C3R pathway not only participates in the process
of microglial phagocytosis but also plays an important role in the
priming of microglia (Fu et al., 2012; Ramaglia et al., 2012; Hong
et al., 2016). These results, together with plump, ameboid, and
phagocyte-like shape of microglia observed after EA treatment,
indicate an active process of phagocytosis during EA treatment.
We refer to microglia/macrophages as microglia in our study
as we have mentioned above. Microglia of anti-inflammatory
M2 phenotype exert lots of protective functions including but
not limited to the phagocytosis of myelin debris and the
recruitment of OPCs. Here in our study we demonstrate the
microglia assembled into CC during EA treatment are more
likely to possess M2 property as compared to CPZ group.
Since M2 microglial cells drive oligodendrocyte differentiation
during CNS remyelination (Miron et al., 2013), this finding,
to some extent, is also indicative of a potential effect of
EA on the recruitment and differentiation of OPC. However,
we did not probe into the effect of EA on OPC in our
current study. O4 is a marker in cells of oligodendrocyte
lineage that appears early on the stage of OPC differentiation
and exists also in mature oligodendrocyte (Schumacher et al.,
2012). Though we found elevated expression of O4 after
EA treatment at week 7, it cannot be explained as a result
of increased OPC differentiation. Following studies focusing
on the effect on OPC differentiation during EA treatment
may quantify the number of Olig2+/APC+ cells to evaluate
differentiation.
Another shortcoming of our current study is that we did
not focus on the reaction of astrocyte as well as the crosstalk
between astrocyte and microglia. It is reported that in cuprizone
model, astrocytes regulate the recruitment of microglia and the
process of myelin debris clearance (Skripuletz et al., 2013). We
are not quite sure about the role of astrocytes in cuprizone model
during EA treatment and our further studies should also pay
attention to it.
In a recent study, the research showed that EA can facilitate
remyelination via promoting the proliferation of oligodendrocyte
and inhibiting its death in SCI model (Huang et al., 2015), and
here we report a new mechanism underlying the remyelinating
effect of EA, which is by recruiting microglia into areas with
demyelinating lesions to clear degraded myelin debris. However,
further studies have to be conducted to understand the neural
pathway and the precise molecular and cellular mechanisms of
how EA regulate microglia recruitment, migration as well as
polarization.
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